l-asparaginase: Need for an Expedition from an Enzymatic Molecule to Antimicrobial Drug

15Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Enzymes play a vital role in the biological system as a catalyst for biochemical reactions. They have a wide range of commercial applications in many areas like the pharmaceutical industry, food industry, etc. l-asparaginase is one of the commercial enzymes with prime importance in anticancer therapy. It is mainly used in chemotherapy; however, it has the potential to cure autoimmune disorders and infectious diseases also. Previous studies reported the antimicrobial potential of l-asparaginase. Therefore, we have discussed the possibility and challenges of the antimicrobial application of l-asparaginase in the treatment of infectious diseases. This is followed by a discussion on the effective delivery of this enzyme using biopolymeric nanocarriers that ensure safe and on target action. The present article gives a perspective on the l-asparaginase molecule that could be developed/established as an approved antimicrobial drug in the future.

Cite

CITATION STYLE

APA

Vimal, A., & Kumar, A. (2022, January 1). l-asparaginase: Need for an Expedition from an Enzymatic Molecule to Antimicrobial Drug. International Journal of Peptide Research and Therapeutics. Springer Science and Business Media B.V. https://doi.org/10.1007/s10989-021-10312-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free